Serological/blood test results for the patients with BCD and control patients throughout follow-up
| ESR (mm/hour) | Anti-dsDNA (IU/mL) | Complement (C3) (g/L) | IgG (g/L) | |||||
|---|---|---|---|---|---|---|---|---|
| Follow-up (months) | BCDT | Control | BCDT | Control | BCDT | Control | BCDT | Control |
| 0 | 62.13±41.5 | 32.89±29.8 | 1113±1699 | 129±233 | 0.68±0.3 | 1.22±1.76 | 17.8±6.1 | 17.8±4.3 |
| 6 | 25.94±14.8 | 21.06±18.5 | 551±984 | 91±207 | 0.87±0.3 | 1.37±2.1 | 14.1±5.3 | 16.8±6.5 |
| 12 | 22.06±16.1 | 18.54±4.4 | 416±851 | 110±262 | 0.89±0.2 | 1.1±0.6 | 15.65±5.6 | 14.75±2.8 |
| 18 | 20.79±18.8 | 21.49±18.9 | 194±346.7 | 105±273 | 0.95±0.3 | 1.01±0.3 | 15.7±6.6 | 15.8±6.9 |
| 24 | 18±13.6 | 22.14±22.1 | 158±208 | 146±512 | 9.98±0.2 | 0.98±0.3 | 10.34±5.4 | 12.17±3 |
| 30 | 19.08±14.5 | 21.34±18.9 | 89.98±91.3 | 61±68 | 0.99±0.24 | 0.99±0.2 | 18.6±5.9 | 12.17±3.6 |
| 36 | 19.42±15.4 | 21.58±25 | 135±168 | 55±69 | 1.05±0.2 | 1.03±0.3 | 14.04±11 | 14.96±11.3 |
| 42 | 18.33±14.5 | 20.82±22.7 | 97.5±112.2 | 83±157 | 1±0.26 | 1±0.25 | 13.44±4.9 | 16.25±5.8 |
| 48 | 15.9±8.2 | 18.26±16.3 | 68.4±93.4 | 70±92 | 1.12±0.23 | 1.03±0.3 | 12.82±7.3 | 17.47±8.7 |
| 54 | 14.1±8.8 | 15.36±13.5 | 54±56.2 | 58±65 | 1.12±0.26 | 0.99±0.23 | 9.7±6.5 | 12.17±2.1 |
| 60 | 14.09±10.7 | 16.18±13.5 | 54±59 | 76±81 | 1.21±0.4 | 1.05±0.3 | 9.35±5.2 | 10.2±2.2 |
BCD, B-cell depletion; BCDT, B-cell depletion treatment; dsDNA, double-stranded DNA; ESR, erythrocyte sedimentation rate.